1. Nasopharyngeal carcinoma: A history2. NPC genetics and genomics3. Pathogenesis of nasopharyngeal carcinoma: histogenesis, EBV infection and tumour microenvironment4. Epidemiology and population screening5. Establishment of NPC cell line, patient-derived xenografts (PDXs) and immortalized nasopharyngeal epithelial cells for NPC and EBV infection study6. Translational studies: Drug candidates and preclinical testing7. Conventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma 8. Imaging of nasopharyngeal carcinoma9. Staging of nasopharyngeal carcinoma based on 8th edition of the AJCC/UICC staging system 10. Standard of care for NPC (2018-2020)11. International consensus on delineation of target volumes and organs at risk12. Advances in radiotherapy13. Salvage of local recurrence14. Management of metastatic nasopharyngeal carcinoma 15. Cancer immunotherapy for nasopharyngeal carcinoma16. Concluding chapter: Nasopharyngeal carcinoma - basic science17. Concluding chapter: Nasopharyngeal cancer - clinical aspects